Chris Leibman is a seasoned executive currently serving as the Senior Vice President and Chief Access Officer at Biogen. They have an extensive background in health economics and market access, previously holding the position of Vice President at Biogen and leading various roles at leading pharmaceutical companies such as Janssen Alzheimer Immunotherapy and Elan Pharmaceuticals. Chris has also contributed to several boards, including the Biotechnology Innovation Organization and MassBio. They are actively involved in academic initiatives as an Advisory Board Member at the University of Washington's CHOICE Institute while pursuing advanced degrees in PharmD and Pharmacoeconomics from the University of Illinois and The Ohio State University, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices